University of Colorado, Denver
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Colorado, Denver sits in the top decile of US sponsors by registered trial count (#21 of 15,742 sponsors by registered trial count).
University of Colorado, Denver: 1,283 sponsored US clinical trials, 265 recruiting.
University of Colorado, Denver sponsors 1,283 registered US clinical trials on ClinicalTrials.gov, 265 of them currently recruiting, and 830 completed. 121 of these trials are in Phase 3-4 (later-stage) and 245 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 23 trials.
Top-decile sponsor footprint
University of Colorado, Denver ranks in the top decile of sponsors by registered trial count (#21 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
830 of 908 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,283 total, page 6 of 26
A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
NCT03617939
Longitudinal Study of Intra-Uterine Growth Restriction
NCT02382601
TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)
NCT02634645
Effect of Alcohol and Drugs of Abuse on Immune Function in Critically Ill Patients With Respiratory Failure
NCT02299921
Study of Placental Function in Healthy and Pathological Pregnancies
NCT02321007
Neuronal Effects of Exercise in Schizophrenia
NCT02455193
Blood Samples for the Study of Peanut, Tree Nut and Other Food Allergies
NCT02192866
The Pediatric Spine Foundation
NCT02540915
DS-Connect®: The Down Syndrome Registry
NCT01950624
Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer
NCT01580982
The Immune System's Response to Young Women's Breast Cancer
NCT01503190
Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth
NCT02273297
Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome (SLOS)
NCT01773278
Specimen Banking From Patients With Lung Cancer
NCT01585675
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
NCT00900419
Forward to Quit: A Person-centered Mobile Technology Intervention for Smoking Cessation Among Transgender Adults
NCT07181551
Understanding and Addressing Rejection of Personalized Breast Cancer Risk Information in Women
NCT06441474
Trial of Atezolizumab, Bevacizumab, and Tiragolumab in Patients With Microsatellite Stable, Metastatic Colorectal Cancer
NCT06784947
Decision Support for Heart Failure Prescribing
NCT06293794
Music During Allogeneic Stem Cell Transplant Hospitalization
NCT06679530
Abridge AI Pilot Test
NCT06778148
Dietary Reversal of the Reprometabolic Syndrome
NCT07227766
Psilocybin for Treatment-Resistant Depression
NCT06230757
Clinical Decision Support to Improve System Naloxone Co-prescribing
NCT06271668
4:3 Intermittent Fasting Intervention in Adults With Breast Cancer and Overweight or Obesity
NCT06399276
Strategy to Avoid Excessive Oxygen Using an Autonomous Oxygen Titration Intervention
NCT06374225
Time and Nutrient-Dependent Effects of Aerobic Exercise on Metabolism in Adults (TANDEM Study)
NCT06311487
Testing the Engaged Approach to Lung Cancer Screening
NCT06327074
Integrated Actionable Aging Assessment for Cancer Patients Pilot
NCT05871008
Deep Brain Stimulation (DBS) for Methamphetamine Use Disorder
NCT05558358
Impact of Vericiguat on Hemodynamics of Heart Failure
NCT05704478
Fully Closed Loop At Home (FCL@Home)
NCT06041971
Tele-Rehabilitation to Improve Mild Traumatic Brain Injury Recovery and Reduce Subsequent Injury Risk
NCT05594225
Amivantamab With Tyrosine Kinase Inhibitors (TKI) for Advanced NSCLC With ALK, ROS1, or RET Alterations
NCT05845671
Therapies for Down Syndrome Regression Disorder
NCT05662228
Underutilization of Hospice Care in Older Black Adults
NCT06408090
Acceptability and Efficacy of Pain Reprocessing Therapy in Racially/ Ethnically Diverse Adults With Chronic Back Pain
NCT05820204
Use of Methazolamide to Lower Intraocular Pressure
NCT05498103
Transfemoral Osseointegrated Prosthesis Limb-Load Symmetry Training
NCT05695911
MitoQ and Exercise Effects on Vascular Health
NCT05686967
Renal Oxygen Consumption, Insulin Sensitivity, and Daily Caloric Restriction in ADPKD
NCT06496542
Study of SBRT/Olaparib Followed by Pembrolizumab/Olaparib in Gastric Cancers
NCT05379972
A Randomized Controlled Trial of No Strings Intrauterine Device (IUD) Removal Techniques
NCT05702242
Effect of Helpers Program On-line Training on Smoking Relapse and Social Networks
NCT05641974
Promoting Informed Choice for Breast Cancer Screening: A Longitudinal Study
NCT05838417
Metabolomics Initiative: Mediterranean-amplified vs Habitual Western Diet on Food Signatures, Health, and Microbiome
NCT05500976
Feasibility of Study of Empagliflozin in Patients With Autosomal Dominant Polycystic Kidney Disease
NCT05510115
Interrogating Fatty Acid Metabolism Impairment and Clinical Correlates in Males with Klinefelter Syndrome
NCT05498090
Evaluating the Effects of Cannabis Use and Circulating Cannabinoids on Tumor Infiltrating Lymphocytes in Malignant Melanoma
NCT05520294
A Study of Evorpacept (ALX148) With Cetuximab and Pembrolizumab for Refractory Microsatellite Stable Metastatic Colorectal Cancer
NCT05167409
What is open in the University of Colorado, Denver pipeline
265 recruiting of 1,283 indexed (21% open); 830 completed (65%).
Phase mix: 121 late (III/IV) vs 245 early (I/II) (early-phase heavy).
Top condition: Obesity (23 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Colorado, Denver: open-pipeline peers nationwide
Peers matched on 1,283 registered trials and 21% open enrollment, not the therapeutic-area sidebar.
University of Colorado, Denver sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,283 trials (± recruiting share)
- AstraZeneca · 1,285 trials · 12% recruiting
- University of Michigan · 1,327 trials · 13% recruiting
- University of Pittsburgh · 1,238 trials · 13% recruiting
- Eli Lilly and Company · 1,341 trials · 9% recruiting
Sponsors near 21% open enrollment (± trial volume)
- Cedars-Sinai Medical Center · 21% recruiting · 339 trials
- Craig Hospital · 21% recruiting · 29 trials
- W.L.Gore & Associates · 21% recruiting · 53 trials
- Georgia Institute of Technology · 21% recruiting · 24 trials
Related
What to do with this University of Colorado, Denver page
1,283 registered trials is a research-attention snapshot, not an endorsement of University of Colorado, Denver or any single study.
- 265 of University of Colorado, Denver's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Colorado, Denver studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Colorado, Denver pipeline card: 1,283 registered trials from official public datasets.Report a data error.